Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4541004
Max Phase: Preclinical
Molecular Formula: C37H58N2O9
Molecular Weight: 674.88
Molecule Type: Unknown
Associated Items:
ID: ALA4541004
Max Phase: Preclinical
Molecular Formula: C37H58N2O9
Molecular Weight: 674.88
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)NCC(=O)N[C@H]1[C@H](O[C@H]2CC[C@@]3(C)C(=CC[C@H]4[C@@H]5C[C@@H]6O[C@]7(CC[C@@H](C)CO7)[C@@H](C)[C@@H]6[C@@]5(C)CC[C@@H]43)C2)O[C@H](CO)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C37H58N2O9/c1-19-8-13-37(45-18-19)20(2)30-27(48-37)15-26-24-7-6-22-14-23(9-11-35(22,4)25(24)10-12-36(26,30)5)46-34-31(39-29(42)16-38-21(3)41)33(44)32(43)28(17-40)47-34/h6,19-20,23-28,30-34,40,43-44H,7-18H2,1-5H3,(H,38,41)(H,39,42)/t19-,20+,23+,24-,25+,26+,27+,28-,30+,31-,32-,33-,34-,35+,36+,37-/m1/s1
Standard InChI Key: QTHMOXQEGVKIGG-UHARPAJUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 674.88 | Molecular Weight (Monoisotopic): 674.4142 | AlogP: 2.80 | #Rotatable Bonds: 6 |
Polar Surface Area: 155.81 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.12 | CX Basic pKa: | CX LogP: 1.76 | CX LogD: 1.76 |
Aromatic Rings: 0 | Heavy Atoms: 48 | QED Weighted: 0.27 | Np Likeness Score: 2.39 |
1. Grzywacz D, Paduszyńska M, Norkowska M, Kamysz W, Myszka H, Liberek B.. (2019) N-Aminoacyl and N-hydroxyacyl derivatives of diosgenyl 2-amino-2-deoxy-β-d-glucopyranoside: Synthesis, antimicrobial and hemolytic activities., 27 (20): [PMID:31153729] [10.1016/j.bmc.2019.05.036] |
Source(1):